FXR agonism protects against liver injury in a rat model of intestinal failure-associated liver disease
Journal Title: Journal of Clinical and Translational Research - Year 2017, Vol 3, Issue 3
Abstract
Background: Intestinal failure-associated liver disease (IFALD) is a clinical challenge. The pathophysiology is multifactorial and remains poorly understood. Disturbed recirculation of bile salts, e.g. due to loss of bile via an enterocutaneous fistula, is considered a major contributing factor. We hypothesize that impaired signaling via the bile salt receptor FXR underlies the development of IFALD. The aim of this study was to investigate whether activation of FXR improves liver homeostasis during chronic loss of bile in rats. Methods: To study consequences of chronic loss of bile, rats underwent external biliary drainage (EBD) or sham surgery for seven days, and the prophylactic potential of the FXR agonist INT-747 was assessed. Results: EBD for 7 days resulted in liver test abnormalities and histological liver damage. Expression of the intestinal FXR target gene Fgf15 was undetectable after EBD, and this was accompanied by an anticipated increase in hepatic Cyp7a1 expression, indicating increased bile salt synthesis. Treatment with INT-747 improved serum biochemistry, reduced loss of bile fluid in drained rats and prevented development of drainage-associated histological liver injury. Conclusions: EBD results in extensive hepatobiliary injury and cholestasis. These data suggest that FXR activation might be a novel therapy in preventing liver dysfunction in patients with intestinal failure. Relevance for patients: This study demonstrates that chronic loss of bile causes liver injury in rats. Abrogated recycling of bile salts impairing of enterohepatic bile salt/FXR signaling underlies these pathological changes, as administration of FXR agonist INT747 prevents biliary drainage-induced liver damage. Pharmacological activation of FXR might be a therapeutic strategy to treat disorders accompanied by a perturbed enterohepatic circulation such as intestinal failure-associated liver disease.
Authors and Affiliations
Kiran V. K. Koelfat, Ruben G. J. Visschers, Caroline M. J. M. Hodin, D. Rudi de Waart, Wim G. van Gemert, Jack P. M. Cleutjens, Marion J. Gijbels, Ronit Shiri-Sverdlov5, Rajeshwar P. Mookerjee6, Kaatje Lenaerts, Frank G. Schaap, Steven W. M. Olde Damink
Keywords
Related Articles
- EP ID EP678772
- DOI -
- Views 195
- Downloads 0
Mechanisms of acetaminophen hepatotoxicity and their translation to the human pathophysiology
Acetaminophen (APAP) overdose is the most common cause of acute liver failure in the United States and mechanisms of liver injury induced by APAP overdose have been the focus of extensive investigation. Studies in the mo...
IL-23 and IL-17A are not involved in hepatic/ischemia reperfusion injury in mouse and man
Background: Hepatic ischemia and reperfusion (I/R) is common in liver surgery and transplantation and compromises postoperative liver function. Hepatic I/R injury is characterized by sterile inflammation that contributes...
Chewing gum and stress reduction
The behavioral effects of chewing gum have been studied for over 80 years and much of the research has been concerned with increases in alertness and attention. Another line of research has addressed the issue of whether...
Legal challenges for the implementation of advanced clinical digital decision support systems in Europe
Systems based on artificial intelligence and machine learning that facilitate decision making in health care are promising new tools in the era of ‘personalized’ or ‘precision’ medicine. As the volume of patient data and...
Proving a negative? Methodological, statistical, and psychometric flaws in Ullmann et al. (2017) PTSD study
Ullmann et al. recently published a pilot study in Translational Psychiatry in which they report failing to find a statistically significant reduction in either hair cortisol or hair cortisone levels in circumcised men a...